Paul Mattels

Stock Analyst at Stifel

(n/a)

# 4,606

Out of 4,876 analysts

4

Total ratings

n/a

Success rate

-37.54%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Paul Mattels

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Upgrades: Buy	$37	$14.10	+162.41%	3	Dec 16, 2024
	ALEC Alector	Initiates: Buy	$44	$1.48	+2,872.97%	1	Feb 19, 2020

Denali Therapeutics

Dec 16, 2024

Upgrades: Buy

Price Target: $37

Current: $14.10

Upside: +162.41%

Alector

Feb 19, 2020

Initiates: Buy

Price Target: $44

Current: $1.48

Upside: +2,872.97%